New drug tested for patients with no other options
Disease control
Recruiting now
This is a first-in-human study testing a new drug called STX-0712 in patients with advanced forms of blood cancer (CMML and AML) who have no remaining standard treatment options. The main goals are to find a safe dose and see if the drug shows any early signs of fighting the canc…
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC